GlassScriptPhysician profile
Marissa C Mcclement
NPI 1275210767
$1,110.57
in general payments reported to CMS, 2019-2025
8 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $136 · 2024: $612 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902 · Travel and Lodging: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.28 |
| Travel and Lodging | $208.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $385.10 | 2024 | Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Edwards Lifesciences Corporation | $201.81 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $200.14 | 2025 | |
| Bolton Medical INC | $137.43 | 2024 | Treo Abdominal Stent-Graft System |
| Astrazeneca Pharmaceuticals LP | $103.40 | 2023 | Andexxa |
| Lemaitre Vascular, INC. | $36.35 | 2024-2025 | Pruitt Irrigation Occlusion Catheter, Restoreflow |
| Solventum Corporation | $28.66 | 2025 | Activ.A.C. |
| Terumo Cardiovascular Systems Corporation | $17.68 | 2024 | Virtuosaph Plus With Radial Indication |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marissa Mcclement listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.